期刊文献+

三阴性乳腺癌临床病理特点及预后因素分析 被引量:33

Clinicopthological features and prognostic factors in triple negative breast cancer
下载PDF
导出
摘要 目的:分析三阴性乳腺癌的临床病理特征和预后影响因素。方法:选取219例具有完整随访结果的浸润性乳腺癌病例,按ER、PR、HER-2表达情况分为三阴性亚群和非三阴性亚群。结果:三阴性亚群中髓样癌及组织学分级3级者所占比例显著高于非三阴性亚群,随访期间,两组患者的复发转移率、无病生存率及总生存率无显著差异。生存分析提示淋巴结状态是三阴性亚群预后的独立影响因素。结论:三阴性乳腺癌的组织学分级高于非三阴性乳腺癌,淋巴结转移状态是三阴性亚群预后的独立影响因素。 Objective :To investigate the clinieopathological ieatures and prognostic tactors m patmnts wire mpm negative breast cancer. Methods :Total of 219 cases with complete follow -up data were categorized into triple nega- tive breast cancer(TNBC) and non -triple negative breast cancer( non -TNBC). Results: In this cohort,69 patients were TNBC. The rates of medullary carcinoma and pathological grade m in TNBC were higher than in those of the non - TNBC. During the follow - up period, no significant differences in prognosis were found between these two subgroups. By univariate and multivariate survival analysis, node status was demonstrated as the independent prognostic factors for TNBC. Conclusion:Patients with TNBC showed higher pathological grade, and node status was demonstrated as the independent prognostic factor for TNBC.
出处 《现代肿瘤医学》 CAS 2013年第2期294-298,共5页 Journal of Modern Oncology
基金 陕西省科技计划项目(编号:S2010SF855)
关键词 三阴性乳腺癌 临床病理特征 预后 triple negative breast cancer clinicopathological feature prognosis
  • 相关文献

参考文献16

二级参考文献113

  • 1赵卫红,徐兵河,张频,李青,赵龙妹,孙燕.乳腺癌合并脉管瘤栓的临床病理特点及预后因素分析[J].中华肿瘤杂志,2007,29(2):137-140. 被引量:14
  • 2石毅然,曲建军,李湘洲,马世庆,王峰,王会东,张永庆,王昌亮.MUC1与HER2基因在乳腺癌中的表达及其与临床病理学指标的相关性研究[J].中国肿瘤临床,2007,34(11):621-624. 被引量:6
  • 3Carey LA, Perou CM, Livasy CA, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA, 2006, 295:2492-2502.
  • 4Carlson RW, Moench SJ, Hammond ME, et al. HER2 testing in breast cancer: NCCN Task Force report and recoannendations. J Natl Compr Canc Netw, 2006, 4 Suppl 3 :S1-22.
  • 5Cleator S, Heller W, Coombes RC. Triple-negative breast cancer: therapeutic options. Lancet Oncol, 2007, 8:235-244.
  • 6Rakha EA, El-Sayed ME, Green AR, et al. Prognostic markers in triple-negative breast cancer. Cancer, 2007, 109:25-32.
  • 7Perez EA, Roche PC, Jenkins RB, et al. HER2 testing in patients with breast cancer: poor correlation between weak positivity by immunohistochemistry and gene amplification by fluorescence in situ hybridization. Mayo Clin Proc, 2002, 77:148-154.
  • 8Kandel MJ, Stadler Z, Masciari S, et al. Prevalence of BRCA1 mutations in triple negative breast cancer (BC). Proc Am Soc Clin Oncol, 2006, 24 :abstr 508.
  • 9Herr A, Gluz O, Ting E, et al. Biological characteristics in triple negative high risk breast cancer and their clinical implications. Proc Am Soc Clin Oncol, 2006, 24 : abstr 20032.
  • 10Livasy CA, Karaca G, Nanda R, et al. Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma. Mod Pathol, 2006, 19:264-271.

共引文献354

同被引文献394

引证文献33

二级引证文献131

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部